| Quarterly
Results ended Sept'05
| |
|
|
|
|
|
(Rs. in Lacs) |
| |
Particulars |
Quarter Ended 30.09.2005 (Unaudited) |
Quarter Ended 30.09.2004 (Unaudited) |
Half Year Ended 30.09.2005 (Unaudited) |
Half Year Ended 30.09.2004 (Unaudited) |
18 Months Period Ended 31.03.2005
(Audited) |
| 1 |
Income from Operations |
2813.01 |
2212.00 |
5045.07 |
4934.00 |
12328.20 |
| 2 |
Other Income |
67.15 |
1.00 |
129.49 |
2.00 |
782.95 |
| |
Total |
2880.16 |
2213.00 |
5174.56 |
4936.00 |
13111.15 |
| |
|
|
|
|
|
|
| 3 |
Total Expenditure |
2489.19 |
2085.00 |
4423.33 |
4461.00 |
12780.03 |
| |
a) ( Increase) / Decrease in stock-in-trade |
(159.42) |
67.00 |
(139.27) |
1.00 |
202.45 |
| |
b) Consumption of Raw Materials |
1987.85 |
1112.00 |
3201.70 |
2564.00 |
6522.21 |
| |
c) Staff Cost |
288.79 |
322.00 |
593.83 |
669.00 |
2133.06 |
| |
d) Other Expenditure |
371.97 |
584.00 |
767.07 |
1227.00 |
3922.31 |
| |
Operating Profit/(Loss) |
390.97 |
128.00 |
751.23 |
475.00 |
331.12 |
| 4 |
Interest |
26.67 |
36.07 |
47.94 |
590.07 |
221.75 |
| 5 |
Depreciation & Amortisation |
1229.23 |
1243.00 |
2458.47 |
2470.00 |
7299.88 |
| 6 |
Profit / (Loss )before Tax |
(864.93) |
(1151.07) |
(1755.18) |
(2585.07) |
(7190.51) |
| 7 |
Provision for Current Tax / Fringe Benefit Tax |
(3.83) |
0.00 |
0.00 |
0.00 |
0.00 |
| 8 |
Provision for Deferred Tax |
(291.14) |
0.00 |
(610.14) |
0.00 |
(2444.49) |
| 9 |
Net Profit / (Loss) |
(569.96) |
(1151.07) |
(1145.04) |
(2585.07) |
(4746.02) |
| 10 |
Paid-up equity share capital |
3200.80 |
3020.80 |
3200.80 |
3020.80 |
3020.80 |
| 11 |
Reserves excluding revaluation reserves |
|
|
|
|
17709.07 |
| 12 |
Earning Per Share (Face Value of Rs.2/-) for the period
(in Rs.) |
|
|
|
|
|
| |
- Basic |
(0.39) |
(1.00) |
(0.71) |
(1.87) |
(3.14) |
| |
- Diluted |
(0.30) |
(0.72) |
(0.54) |
(1.40) |
(2.25) |
| 13 |
Aggregate of Non-Promoter Shareholding |
|
|
|
|
|
| |
- Number of Shares |
140708412 |
137199508 |
140708412 |
137199508 |
137708412 |
| |
- Percentage of Shareholding |
87.92% |
90.84% |
87.92% |
90.84% |
91.17% |
-
The above results have been taken on record by the Board
of Directors in its meeting held on 27th October, 2005.
-
The Company is exclusively engaged in the Pharmaceutical
Business segment. The Capital employed as on 30th September,
2005 is Rs.110062.19 Lacs.
-
During the Quarter, Doctor Morepen Ltd. became wholly
owned subsidiary as a sequel to the acquisition of its
Equity Capital. Consequently, Total Care Ltd. has also
now become a subsidiary of the Company.
-
During the Quarter, 90,00,000 Equity shares of Face value
Rs.2 per share were issued to the Promoter group at a
premium of Rs.9 per share. Subsequently, the Promoter
group has also been alloted 5,10,00,000 Equity Shares
of Face Value Rs.2 each at a premium of Rs.9 per share.
These allotments have been made pursuant to rights attached
to the warrants issued earlier.
-
Pending approval of scheme of Compromise and Arrangement
filed with the Hon'ble High Court at Shimla (H.P.) interest
for this quarter amounting to Rs.2261.99 Lacs has not
been provided for.
-
GDR proceeds of USD 15.25 million are locked up due to
the pending litigations.
-
During the Quarter, 1 shareholder's complaint was received,
which was resolved.
For Morepen Laboratories Limited
(Sushil Suri)
Chairman & Managing Director
Place : New Delhi
Date : 30.10.2005
|
